Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-010501
Filing Date
2017-11-01
Accepted
2017-11-01 16:06:32
Documents
83
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-09302017.htm 10-Q 1228368
2 EXHIBIT 31.1 exhibit311-09302017.htm EX-31.1 13550
3 EXHIBIT 31.2 exhibit312-09302017.htm EX-31.2 13558
4 EXHIBIT 32.1 exhibit321-09302017.htm EX-32.1 8790
5 EXHIBIT 32.2 exhibit322-09302017.htm EX-32.2 8806
  Complete submission text file 0001628280-17-010501.txt   7439191

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20170930.xml EX-101.INS 1646288
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20170930.xsd EX-101.SCH 55750
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20170930_cal.xml EX-101.CAL 92320
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20170930_def.xml EX-101.DEF 242094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20170930_lab.xml EX-101.LAB 748018
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20170930_pre.xml EX-101.PRE 429339
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 171168978
SIC: 2834 Pharmaceutical Preparations